Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The North American generics market had total revenues of $82.2 billion in 2022, representing a compound annual growth rate (CAGR) of 2.3% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 0.7% between 2017 and 2022, to reach a total of 85.3% in 2022.
- Factors such as accelerating healthcare costs and increasing abbreviated new drug application (ANDA) approvals are driving the generics market. According to the Food & Drug Administration’s (FDA) Office of Generic Drugs (OGD) 2022 Annual Report, in 2022, the generic drug program issued or tentatively authorized 914 ANDAs for generic drugs.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in North America
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the North America generics market by value in 2022?
- What will be the size of the North America generics market in 2027?
- What factors are affecting the strength of competition in the North America generics market?
- How has the market performed over the last five years?
- Who are the top competitors in North America's generics market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teva Pharmaceutical Industries Limited
- Viatris Inc.
- Pfizer Inc.
